Dortmund and Berlin, Germany, June 25, 2012
PRINCETON, N. J., USA, and Berlin, Germany, June 25, 2012 — SCIENION US, Inc. today announced that Courtagen Life Sciences, Inc. – a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry – will use SCIENION’s sciFLEXARRAYER technology to produce innovative biochips for multiplex immunoassays, and collaborate with Scienion to meet future manufacturing and market needs.

Dortmund and Berlin, Germany, May 25, 2012
Scienion launches the new version of its sciFLEXARRAYER S1 at European Lab Automation in Hamburg, May 30-31. The small compact non-contact piezo dispensing roboter with an increased throughput and versatility offers precise ultra-low volume liquid handling for a variety of applications in multiplexed diagnostics and cellular screening approaches.

Dortmund and Berlin, Germany, March 20, 2012
SCIENION AG today announced the introduction of its sciREADER CL for colorimetric detection of multiplex assays. With the sciREADER Scienion extends its product portfolio in order to provide customers with best quality equipment for total multiplexing solutions.

Dortmund and Berlin, Germany, December 6, 2011
SCIENION AG today announced the foundation of an US subsidiary in Princeton, New Jersey. In the year of its tenth company anniversary Scienion starts selling its products and services directly into the North American market. Dr. Holger Eickhoff, CEO of Scienion AG, stated: “After having started our US activities five years ago with an US-based distributor, now our business in this key market is growing to an extent that we decided to build our own base with a Scienion subsidiary in New Jersey. This step is a consequence of increasing demands not only for our sciFLEXARRAYER dispensers but also for our contract manufacturing services. Thus, we will also establish a contract manufacturing unit in North America. I am sure our North American customers will benefit from our presence in the US.”

Dortmund and Berlin, October 6, 2011
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW. SCIENION AG today announced that the planned acquisition by Canadian SQI Diagnostics Inc. will not be realized. The share purchase agreement was terminated.

Dortmund and Berlin, Germany, July 4, 2011
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW. Scienion AG, a German-based microarray manufacturing equipment and microarray print and development services company today announced that it has entered into an agreement to be acquired by SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. SQI will acquire all of the share capital of Scienion AG.

Dortmund and Darmstadt, Germany, June 27, 2011
SCIENION AG today has announced that R-Biopharm AG – a leading developer of products for clinical diagnostics and food & feed analysis – will use SCIENION’s sciFLEXARRAYER technology to produce innovative chips for the detection of antibiotic residues in milk.Read more…

Dortmund and Berlin, Germany, April 19, 2011
Scienion AG today announced that the company will produce protein microarray batches for clinical validation studies of proprietary biomarker panels of Protagen AG. The batch sizes will comprise more than 1000 arrays. Additionally, both companies plan to jointly evaluate new platforms for multiplex analytics and to co-develop novel approaches up to proof-of-concept levels under a strategic partnership.

Dortmund and Berlin, Germany, February 21, 2011
Scienion AG announced today that EUROIMMUN AG – one of the leading manufacturers of immuno-biochemical assays – has purchased Scienion’s sciFLEXARRAYER technology to develop multiplexed diagnostic products and to produce new test formats.

Dortmund and Berlin, Germany, November 3, 2010
“From Sample to Assay – From R&D to IVD” was the title of a two-day workshop Scienion AG hosted in Berlin recently. Almost 100 participants from 12 countries benefited from an outstanding program covering topics from latest research applications, technology improvements to production issues.

Dortmund and Berlin, Germany, June 17, 2010
Scienion’s innovative dispensing technology is excellently suited for a variety of applications wherever contact-free precise handling of ultra low volume liquids is needed. For Prof. Peter H. Seeberger, Max Planck Institute of Colloids and Interfaces, the sciFLEYXARRAYER proved to be the best choice for the production of carbohydrate arrays.

Dortmund and Berlin, Germany, April 8, 2009
Scienion’s innovative dispensing technology is excellently suited for a variety of applications wherever contact-free precise handling of ultra low volume liquids is needed. Analytik Jena eBiochip GmbH recently started using this technology to coat electrical biochips. Die ultra low volume Dispensiertechnik der Scienion AG eignet sich hervorragend für eine Vielzahl von Anwendungen, bei denen es auf das berührungsfreie und präzise Handling kleinster Flüssigkeitsmengen ankommt. Die Analytik Jena eBiochip GmbH nutzt die Technologie seit kurzem, um neuartige elektrische Biochips damit zu bedrucken.